These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10608425)

  • 1. New millennium bronchodilators for asthma: single-isomer beta agonists.
    Handley DA; Anderson AJ; Koester J; Snider ME
    Curr Opin Pulm Med; 2000 Jan; 6(1):43-9. PubMed ID: 10608425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-isomer beta-agonists.
    Handley DA
    Pharmacotherapy; 2001 Mar; 21(3 Pt 2):21S-27S. PubMed ID: 11253864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
    Aziz I; Lipworth BJ
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The asthma-like pharmacology and toxicology of (S)-isomers of beta agonists.
    Handley D
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S69-76. PubMed ID: 10452791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
    FitzGerald JM; Chapman KR; Della Cioppa G; Stubbing D; Fairbarn MS; Till MD; Brambilla R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):427-35. PubMed ID: 10069876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting properties of albuterol stereoisomers.
    Page CP; Morley J
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S31-41. PubMed ID: 10452786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of enantiomers of beta 2-agonists on ACh release and smooth muscle contraction in the trachea.
    Zhang XY; Zhu FX; Olszewski MA; Robinson NE
    Am J Physiol; 1998 Jan; 274(1):L32-8. PubMed ID: 9458798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological similarities and differences between beta2-agonists.
    Lötvall J
    Respir Med; 2001 Aug; 95 Suppl B():S7-11. PubMed ID: 11534896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting beta 2-agonists.
    Tattersfield AE
    Clin Exp Allergy; 1992 Jun; 22(6):600-5. PubMed ID: 1356604
    [No Abstract]   [Full Text] [Related]  

  • 11. Actions other than smooth muscle relaxation may play a role in the protective effects of formoterol on the allergen-induced late asthmatic reaction.
    Brusasco V; Crimi E; Gherson G; Nardelli R; Oldani V; Francucci B; Della Cioppa G; Senn S; Fabbri LM
    Pulm Pharmacol Ther; 2002; 15(4):399-406. PubMed ID: 12220946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the enantiomers of formoterol on inherent and induced tone in guinea-pig trachea and human bronchus.
    Schmidt D; Källström BL; Waldeck B; Branscheid D; Magnussen H; Rabe KF
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):405-9. PubMed ID: 10763855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peak inspiratory flow rate after methacholine challenge in asthmatic patients and its impact on the effect of formoterol via different inhalers.
    Haidl P; Schmidt F; Wiese C; Koehler D
    J Aerosol Med; 2006; 19(3):364-71. PubMed ID: 17034311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the anti-bronchoconstrictor activities of inhaled formoterol, its (R,R)- and (S,S)-enantiomers and salmeterol in the rhesus monkey.
    Fozard JR; Buescher H
    Pulm Pharmacol Ther; 2001; 14(4):289-95. PubMed ID: 11440557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with levalbuterol.
    Nelson HS
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S77-84. PubMed ID: 10452792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchial hyperresponsiveness induced by chronic treatment with albuterol: Role of sensory nerves.
    Keir S; Page C; Spina D
    J Allergy Clin Immunol; 2002 Sep; 110(3):388-94. PubMed ID: 12209084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta2-agonist eutomers: a rational option for the treatment of asthma?
    Boulton DW; Fawcett JP
    Am J Respir Med; 2002; 1(5):305-11. PubMed ID: 14720033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levalbuterol in the treatment of patients with asthma and chronic obstructive lung disease.
    Dalonzo GE
    J Am Osteopath Assoc; 2004 Jul; 104(7):288-93. PubMed ID: 15293593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levalbuterol hydrochloride.
    Slattery D; Wong SW; Colin AA
    Pediatr Pulmonol; 2002 Feb; 33(2):151-7. PubMed ID: 11802253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid onset of tolerance to beta-agonist bronchodilation.
    Haney S; Hancox RJ
    Respir Med; 2005 May; 99(5):566-71. PubMed ID: 15823453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.